Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommadossi

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Reviews of Infectious Diseases|July 1, 1988
Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal functionJ P Sommadossi, R Bevan, T Ling, et al.
Journal of Medicinal Chemistry|December 20, 1996
Synthesis, biotransformation, and pharmacokinetic studies of 9-(beta-D-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathwayL P Kotra, K K Manouilov, E Cretton-Scott, et al.
Journal of Clinical Pharmacology|March 1, 1997
Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virusX J Zhou, K Squires, X R Pan-Zhou, et al.
AIDS (London, England)|January 12, 2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsX J Zhou, D V Havlir, D D Richman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblastsW Lewis, E S Levine, B Griniuviene, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activityL Placidi, E Cretton-Scott, G Gosselin, et al.
Toxins|February 25, 2025
The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive ReviewMartina Ferrillo, Eleonora Sommadossi, Loredana Raciti, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with <i>In Vitro</i> and <i>In Vivo</i> Activity against Dengue and Other FlavivirusesSteven S Good, Ashleigh Shannon, Kai Lin, et al.
Biochemical Pharmacology|November 22, 1996
Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicityL Cui, R F Schinazi, G Gosselin, et al.
Antiviral Chemistry & Chemotherapy|November 13, 2004
Synthesis, physicochemical and pharmacokinetic studies of potential prodrugs of beta-L-2'-deoxycytidine, a selective and specific anti-HBV agentClaire Pierra, Samira Benzaria, David Dukhan, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Reviews of Infectious Diseases|July 1, 1988
Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal functionJ P Sommadossi, R Bevan, T Ling, et al.
Journal of Medicinal Chemistry|December 20, 1996
Synthesis, biotransformation, and pharmacokinetic studies of 9-(beta-D-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathwayL P Kotra, K K Manouilov, E Cretton-Scott, et al.
Journal of Clinical Pharmacology|March 1, 1997
Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virusX J Zhou, K Squires, X R Pan-Zhou, et al.
AIDS (London, England)|January 12, 2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsX J Zhou, D V Havlir, D D Richman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 1996
Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblastsW Lewis, E S Levine, B Griniuviene, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activityL Placidi, E Cretton-Scott, G Gosselin, et al.
Toxins|February 25, 2025
The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive ReviewMartina Ferrillo, Eleonora Sommadossi, Loredana Raciti, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with <i>In Vitro</i> and <i>In Vivo</i> Activity against Dengue and Other FlavivirusesSteven S Good, Ashleigh Shannon, Kai Lin, et al.
Biochemical Pharmacology|November 22, 1996
Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicityL Cui, R F Schinazi, G Gosselin, et al.
Antiviral Chemistry & Chemotherapy|November 13, 2004
Synthesis, physicochemical and pharmacokinetic studies of potential prodrugs of beta-L-2'-deoxycytidine, a selective and specific anti-HBV agentClaire Pierra, Samira Benzaria, David Dukhan, et al.
Pageof 18